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Abstract
Tobacco use is the leading cause of preventable death in Ireland with
almost 6,000 smokers dying each year from smoking-related diseases.
Amongst younger Irish women, smoking rates are considerably higher in
those from socially disadvantaged areas compared to women from affluent
areas. Women from poorer areas also experience higher rates of lung
cancer. To our knowledge, there are no peer reviewed published
systematic reviews on the effectiveness of interventions tailored to reduce
smoking rates in women from disadvantaged areas. This systematic review
protocol will aim to examine the effectiveness of such interventions and to
describe trial processes such as recruitment, follow-up and dropout
prevention strategies, as well as barriers and enablers of successful
implementation.   
A systematic review will be conducted of peer-reviewed randomised
controlled trials and associated process evaluations of smoking cessation
interventions designed for women living in socially disadvantaged areas. If
the search returns, less than five studies are review criteria will expand to
include quasi-experimental studies. A number of databases of scholarly
literature will be searched from inception using a detailed search strategy.
Two independent reviewers will screen titles, abstracts and full-text articles
to identify relevant studies using a pre-defined checklist based on PICOS.
In the case of disagreement, a third reviewer will be consulted. The quality
of included studies will be assessed using the ‘Grading of
Recommendations Assessment, Development and Evaluation’ (GRADE)
criteria. Quantitative data will be extracted and, if comparable, will be
assessed using meta-analysis. A narrative meta-synthesis of qualitative
data will be conducted.  
This review aims to synthesise information from relevant studies on
smoking cessation interventions tailored for women from socially
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smoking cessation interventions tailored for women from socially
disadvantaged areas. The evidence obtained from studies and presented in
this review will help guide future research in this area.
This review will be registered with International ProspectiveRegistration: 
Register of Systematic Reviews (PROSPERO).
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Introduction
Tobacco smoking remains the leading cause of morbidity 
and mortality globally. According to a recent World Health 
Organisation (WHO) report, tobacco kills more than 7 million 
people each year1. More than 6 million of those deaths are the 
direct result of tobacco use, with 890,000 caused by non- 
smokers’ exposure to second-hand smoke. Compared to the rest 
of the world, the WHO European Region has one of the highest 
proportions of deaths attributable to tobacco use. WHO 
estimates that tobacco use is responsible for 16% of all deaths 
in adults over 30 years in the European Region, with many of 
these occurring prematurely2.
The Healthy Ireland Survey 2018 reported 20% of people aged 
15 years are current smokers; with a rate of 22% in men and 
17% in women3. Cigarette smoking prevalence were highest 
among 25 to 34-year olds, with rates declining with age3.
While tobacco use was previously largely a male phenomenon, 
the gap in prevalence between genders is now less than 5% in 
countries such as Denmark, the Netherlands, Sweden and the 
United Kingdom4. However, research has highlighted that 
gender remains an important factor when considering smoking 
prevalence in areas of deprivation. A recent report by Health 
Ireland Survey (2018)3 found that smoking rates were higher 
in more disadvantaged areas than in affluent areas (26% versus 
16%, respectively). Women aged 18 to 29 from the lowest 
socioeconomic groups in Ireland have been reported to have 
almost double the smoking rate compared to those belonging 
to affluent groups (56% versus 28%)5. This disparity was also 
observed in men, although the difference was less pronounced 
(44% versus 31%)5.
Smoking perpetuates health inequalities between women 
from richer and poorer communities. Data from 2016 found 
significantly higher lung cancer rates in women from the most 
deprived areas of Ireland versus women from the least deprived 
(age standardised rate ratio, 1.56; 95% CI, 1.42 1.72)6. Lung 
cancer incidence in Irish men has declined in the period from 
1994 to 2015, but has increased in women over the same 
period7. More women in Ireland are now dying from lung 
cancer than breast cancer8. Smoking can have differential 
effects on women’s health such as increased risk of cervical 
cancer, breast cancer and premature menopause9, and there 
may be a cumulative effect of disadvantage on women who 
smoke and their health outcomes. These results suggest female 
smokers from more disadvantaged groups should be targeted 
for greater support in smoking cessation, and there have been 
recent calls for the development of tailored interventions in 
this area10.
In a previous systematic review of randomised controlled 
trials (RCTs) of smoking trials, women had more difficulty 
in maintaining long-term abstinence compared to men11. A 
general population survey across several countries found that 
amongst people aged under-50, women were more likely to stop 
smoking completely compared to men, but amongst older 
groups, men were more likely to quit than women12. It is likely 
deprivation and gender interact to accentuate these differences 
and there is a need to expand and explore the scope of such 
findings.
To our knowledge there are no peer reviewed, published 
systematic reviews that examine the smoking cessation inter-
ventions targeted at women living in disadvantaged areas. A 
previous narrative review assessed gender differences in 
smoking cessation11 but did not specifically explore the role of 
disadvantage. This systematic review will evaluate the effective 
of smoking cessation interventions tailored to women living in 
disadvantaged areas.
Aims and research objectives
This systematic review protocol sets out to identify, appraise 
and synthesise the existing evidence of effectiveness of smoking 
cessation programmes available to women living in disadvantaged 
communities. 
The review will address the following research objectives:
1.    Assess the effectiveness of intervention programmes for 
smoking cessation in women living in disadvantaged 
communities;
2.    Identify the recruitment strategies used by these 
programmes and quantify their success in the recruitment 
of participants;
3.    Identify the retention, drop-out and follow-up rates of the 
programmes;
4.    Identify the implementation strategies used by these 
programmes, e.g. training, coaching.
5.    Identify the barriers and enablers to successful implementa-
tion of the programmes.
Methods
A systematic review of peer-reviewed literature will be 
conducted on smoking cessation and quit-tobacco interven-
tions for women living in socially deprived areas. The proposed 
review will be guided by the “Preferred Reporting Items for 
Systematic Review and Meta-Analysis Protocols” (PRISMA-P) 
checklist13; a completed PRISMA-P checklist is available14. 
This review protocol will be registered with PROSPERO 
(awaiting registration number).
Study design
The systematic review will consider RCTs and associated process 
evaluations. If the search returns fewer than five studies, review 
criteria will be expanded to include quasi-experimental studies 
of smoking cessation interventions designed for women living in 
socially disadvantaged areas.
Search strategy
The strategy aims to find published articles by a systematic 
search of Medline, Embase, Cochrane Library of Systematic 
Reviews, Cinahl, PsycINFO, Web of Science, Scopus, Socio-
logical Abstracts, ASSIA, British Nursing Index, Google Scholar, 
Epistemonikos, with relevant MeSH headings. An experienced 
librarian (D.M.) will develop a sensitive search strategy for each 
individual database. There will be no restriction on country or 
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year of publication; however, all papers must be in English. 
Where studies are not available we will contact study authors. 
This study will exclude grey literature, conference abstracts, 
opinion pieces, literature reviews commentaries and editori-
als. Bibliographies of all retrieved trials and other relevant 
publications, including reviews and meta-analyses will be 
checked for additional relevant articles.
Study eligibility
The terms of this review will be defined using PICOS (Population, 
Intervention, Comparison, Outcome, and Study Design).
Population
Women aged 18 years and above that are reported as being 
from disadvantaged communities who smoke and who have 
attended any type of smoking cessation programme.
Intervention
Intervention programmes that report smoking cessation 
outcomes at end of programme delivery and follow-up including 
any recruitment strategies used in the studies. 
‘Smoking cessation interventions’ will be defined as interven-
tions that are designed to assist smoking cessation. These are 
predicted to consist of the following:
•    Any RCTs that report individual–level interventions 
such as (i) brief advice to stop smoking from a health 
professional (e.g. physician); (ii) pharmacotherapy (nico-
tine replacement therapies such as the transdermal patch, 
chewing gum, nasal sprays, lozenges, inhalers, dissolv-
able strips, and prescribed or self-administered alternatives 
to tobacco such as bupropion/varenicline or e-cigarettes); 
or (iii) behavioural support (any form of encourage-
ment, advice or discussion from a trained stop-smoking 
specialist).
•    Any RCTs that report accompanying process evalua-
tions that focus on implementation strategies, barriers and 
facilitators to the implementation of the intervention 
during the programmes.
Comparison
Corresponding information will be extracted for the control arm 
of RCTs, typically ‘care as usual’.
Outcome
The primary outcome of interest is the proportion of the 
population randomised who achieve smoking cessation 
(e.g. abstinence). Smoking cessation will be defined as an 
intention-to-stop smoking cigarettes from a given point in time 
(e.g., a ‘quit attempt at 4 weeks’), followed by resistance of 
urges to smoke, resulting in a period of abstinence15, that will be 
corroborated by a saliva test. 
Secondary outcomes will be proportions of the population 
i) recruited from those eligible; ii) retained at the end of the 
intervention; and iii) retained at subsequent follow-up data 
collection points.
Study design
Inclusion criteria 
-    RCTs trials of women aged 18 years and above who 
smoke and have attended any type of smoking cessation 
programme and live in disadvantaged communities.
-    RCTs with both men and women in the same sample, if 
all findings were reported separately for women.
-    RCTs with a sample of pregnant and non-pregnant 
women, if smoking cessation is reported separately for 
non-pregnant women.
-    RCTs that include women living in any circumstances, 
but the results are segmented into smoking cessation for 
women in disadvantaged communities.
-    Any definition of “Disadvantaged communities” (including 
but not limited to poverty, low income, unemployment, 
educational status, social class, social condition, 
neighbourhood/area status)16.
Exclusion criteria. This review will exclude studies that 
are exclusive to pregnant women.
Data selection and management
The title and abstracts retrieved from the electronic databases 
and references will be exported to EndNote bibliographic 
software for storage and the removal of duplicates. After 
removal of duplicates, the title and abstracts will be exported to 
Covidence software for reviewing17. Two independent reviewers 
will identify relevant titles and abstracts using a pre-defined 
checklist based on PICOS. If the reviewers deviate in their 
judgement, a third reviewer will assess these abstracts. The 
full text version will be obtained for the remaining relevant 
searches. The two independent reviewers will review the 
full text and those deemed irrelevant will be removed. Any 
disagreements that arise between the two reviewers will be 
resolved through discussion with a third reviewer13.
Quality assessment for risk of bias
Two reviewers will independently check each selected article 
to minimise bias. All selected articles will be judged for their 
quality based on the Grading of Recommendations Assess-
ment, Development and Evaluation’ (GRADE) system18. The 
GRADE approach provides guidance on rating the qual-
ity of research evidence in health care. This system addresses 
the five main factors that can downgrade the quality scores of 
RCTs18, which include risk of bias, inconsistency, indirect-
ness, imprecision and publication bias. Evidence from non- 
randomised studies begins as low-quality evidence, but ratings 
can be upgraded (provided no other limitations have been 
identified according to the five factors). Upgrading occurs if 
there is a large magnitude of effect, evidence of a dose-response 
effect, and all plausible confounding factors have been taken 
into account19. An advantage of GRADE is that it leads to more 
transparent judgements about the quality of evidence and can 
help indicate the strength of recommendations based on the 
evidence20. The GRADE approach is comprehensively described 
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in an online manual19 (freely available for download with the 
GRADEpro software).
Data extraction
Using standardized data extraction forms, two reviewers will 
extract data from valid and selected papers for data analysis. 
The data extracted will include details specific to the review’s 
primary and secondary outcomes and fulfils the requirements 
for the both the outcomes and a potential meta-analysis. All 
corresponding authors will be contacted for key information 
when data are ambiguous or missing from the published study. 
Data extraction will be independently crosschecked, reviewers 
will resolve disagreements by discussion, and a third reviewer 
will resolve unresolved disagreements.
Data synthesis
For quantitative data, where possible, odds ratios for binary 
outcome data and their 95% confidence intervals will be calcu-
lated from data generated by each included RCT. Data derived via 
intention-to-treat analysis will be used. If possible, results from 
comparable groups of studies will be pooled into statistical 
meta-analysis using Review Manager software from the Cochrane 
Collaboration21.
Statistical heterogeneity between combined studies will be 
tested using the I2 method alongside the standard chi-square 
test. An estimate greater than or equal to 50% accompanied by a 
statistically significant Chi2 statistic will be interpreted as 
evidence of statistical heterogeneity22. If substantial levels of 
heterogeneity are found for the primary outcome measure, all 
data entered will be checked for accuracy, then a visual inspec-
tion of the data will take place and removal of outlying studies 
will be carried out to assess if heterogeneity persists. Sub- 
group analyses will be completed if sufficient data are available 
to examine between-study variability on, for example categories 
of intervention, or risk of bias.
The unit of analysis is expected to be at an individual level 
outcome. Where ‘cluster randomisation’ is used, these data 
will be extracted alongside an assessment of whether the authors 
accounted for intra-class correlation (ICC) in clustered studies. 
Where clusters have not been incorporated into the analysis 
of the trial, authors will be contacted and asked to provide the 
ICCs for their clustered data. These binary data derived from 
randomised cluster trials will then be divided by a ‘design 
effect’, estimated using the mean number of participants per 
cluster (m) and the ICC using the formula (Design effect = 
1 + (m−1) × ICC]23). If the ICC cannot be obtained, we will 
assume it to be 0.124.
For any particular outcome, if more than 50% of data were 
unaccounted for, we will not use these in any meta-analysis. A 
random effects model will be used in preference to a fixed-effects 
model to combine individual RCT primary outcome measures 
as it takes into account that different trials are estimating 
different but related intervention effects.
Where statistical pooling is not possible the findings will be 
presented in narrative form. Heterogeneous qualitative data 
will be synthesised in a narrative format focused around the 
review’s objectives with findings presented thematically; 
however, where possible, meta-analysis will be carried out on 
homogenous data.
Discussion
This review will systematically examine the available evidence 
of effectiveness on smoking cessation interventions in women 
from socially disadvantaged areas. By summarising recruitment 
implementation strategies and barriers. It is hoped that these 
findings will help direct future research and smoking cessation 
policy. This review will focus on RCTs and associated proc-
ess evaluations. If the search returns fewer than five studies, the 
review criteria will expand to include quasi-experimental 
studies. There is no restriction to the country of origin or year of 
publication, however all language must be in English. The aim 
of this review RCT is to help guide future smoking cessation 
programmes for women from disadvantaged areas.
Limitations
There are some limitations to the outlined systematic review. 
The restriction to English is acknowledged as a language bias. 
The cost of high-quality translations of in-depth qualitative data 
are beyond the resources of this review; however, non-English 
language studies identified at the screening stages and excluded 
from the synthesis will be listed in an appendix to the review to aid 
future reviewers.
Data availability
Underlying data
No underlying data are associated with this article.
Reporting guidelines
Open Science Framework: PRISMA-P checklist for “Smok-
ing cessation programmes for women living in disadvantaged 
communities, “We Can Quit”: A systematic review protocol”. 
https://doi.org/10.17605/OSF.IO/J96M514.
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